ask="3.000"
ask_size="200"
average_daily_volume="507310"
bid="2.700"
bid_size="5000"
book_value="3.561"
change="-0.055"
change_from_200_day_moving_average="-2.061"
change_from_50_day_moving_average="0.301"
change_from_52_week_high="-6.655"
change_From_52_week_low="0.695"
change_in_percent="-2.000%"
close="2.695"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.031"
ebitda="-31.76M"
eps_estimate_current_year="-1.160"
eps_estimate_next_quarter="-0.280"
eps_estimate_next_year="-0.800"
ex_dividend_date="N/A"
float_shares="8386000"
high="2.750"
high_52_weeks="9.350"
last_trade_date="3/3/2017"
last_trade_price="2.695"
last_trade_size="290"
last_trade_time="3:59pm"
low="2.650"
low_52_weeks="2.000"
market_capitalization="42.19M"
moving_average_200_day="4.756"
moving_average_50_day="2.394"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.630"
open="2.750"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-43.334%"
percent_change_from_50_day_moving_average="+12.588%"
percent_change_from_52_week_high="-71.176%"
percent_change_from_52_week_low="+34.750%"
previous_close="2.750"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.772"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.640"
stock_exchange="NGM"
symbol="NVLS"
volume="131868"
weeks_range_52="2.000 - 9.350"
